Skip to content


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
  • Email this article
  • View or print a PDF of this page
  • Share further
  • Add this article to your Pinterest board
  • Add this article to your Google page
  • Share this article on Reddit
  • Share this article on StumbleUpon
  • Bookmark this page

More Americans rely on handouts for affordable medication

Martin Parkinson, life sciences expert at PA Consulting Group is quoted in an article in the 'Special Report, FT Health: Access to Healthcare' which discusses the affordability of American healthcare. 

The article examines Patient assistant programmes (PAPs) and assesses whether they may end up adding to the cost of healthcare. It also states that healthcare executives think that more sustainable solutions are needed to improve affordability. 

Building on this, Martin states that PAPs distract attention from finding a long-term solution to the problem of affordable drugs. He says: “They can create the illusion that affordability is not a problem because there is a mechanism through which all patients can access medicines irrespective of income.”

He goes on to say that healthcare pricing demands broader attention from the industry, policy makers and others.

He concludes that: “We need to look more comprehensively at the issue of affordability for patients, healthcare systems and the life sciences industry. There have been many solutions suggested by all stakeholders but we still find ourselves applying band aids to the problems.” 


Contact the life sciences team

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.